262 related articles for article (PubMed ID: 19264776)
1. Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.
Liu J; Ruckwardt TJ; Chen M; Johnson TR; Graham BS
J Virol; 2009 May; 83(10):4934-41. PubMed ID: 19264776
[TBL] [Abstract][Full Text] [Related]
2. Determining the breadth of the respiratory syncytial virus-specific T cell response.
McDermott DS; Knudson CJ; Varga SM
J Virol; 2014 Mar; 88(6):3135-43. PubMed ID: 24371055
[TBL] [Abstract][Full Text] [Related]
3. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
[TBL] [Abstract][Full Text] [Related]
4. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Virol; 1997 Jan; 71(1):678-85. PubMed ID: 8985399
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo.
Aung S; Tang YW; Graham BS
J Virol; 1999 Nov; 73(11):8944-9. PubMed ID: 10515999
[TBL] [Abstract][Full Text] [Related]
6. Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.
Schijf MA; Kruijsen D; Bastiaans J; Coenjaerts FE; Garssen J; van Bleek GM; van't Land B
J Virol; 2012 Nov; 86(21):11472-82. PubMed ID: 22896622
[TBL] [Abstract][Full Text] [Related]
7. Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon.
Bembridge GP; Lopez JA; Cook R; Melero JA; Taylor G
J Virol; 1998 May; 72(5):4080-7. PubMed ID: 9557697
[TBL] [Abstract][Full Text] [Related]
8. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
[TBL] [Abstract][Full Text] [Related]
9. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.
Varga SM; Wissinger EL; Braciale TJ
J Immunol; 2000 Dec; 165(11):6487-95. PubMed ID: 11086089
[TBL] [Abstract][Full Text] [Related]
10. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
Spender LC; Hussell T; Openshaw PJ
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
[TBL] [Abstract][Full Text] [Related]
11. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.
Dulek DE; Newcomb DC; Toki S; Goliniewska K; Cephus J; Reiss S; Bates JT; Crowe JE; Boyd KL; Moore ML; Zhou W; Peebles RS
J Virol; 2014 Sep; 88(17):9655-72. PubMed ID: 24920804
[TBL] [Abstract][Full Text] [Related]
12. CD4(+) T cell frequencies and Th1/Th2 cytokine patterns expressed in the acute and memory response to respiratory syncytial virus I-E(d)-restricted peptides.
Tripp RA; Hou S; Etchart N; Prinz A; Moore D; Winter J; Anderson LJ
Cell Immunol; 2001 Jan; 207(1):59-71. PubMed ID: 11161454
[TBL] [Abstract][Full Text] [Related]
13. The role of IFN in respiratory syncytial virus pathogenesis.
Durbin JE; Johnson TR; Durbin RK; Mertz SE; Morotti RA; Peebles RS; Graham BS
J Immunol; 2002 Mar; 168(6):2944-52. PubMed ID: 11884466
[TBL] [Abstract][Full Text] [Related]
14. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
[TBL] [Abstract][Full Text] [Related]
15. Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.
Plotnicky-Gilquin H; Cyblat-Chanal D; Aubry JP; Champion T; Beck A; Nguyen T; Bonnefoy JY; Corvaïa N
J Virol; 2002 Oct; 76(20):10203-10. PubMed ID: 12239295
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities.
Ruckwardt TJ; Bonaparte KL; Nason MC; Graham BS
J Virol; 2009 Apr; 83(7):3019-28. PubMed ID: 19153229
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.
Lee S; Miller SA; Wright DW; Rock MT; Crowe JE
J Virol; 2007 Mar; 81(5):2349-58. PubMed ID: 17182672
[TBL] [Abstract][Full Text] [Related]
18. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
19. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection.
Chang J; Srikiatkhachorn A; Braciale TJ
J Immunol; 2001 Oct; 167(8):4254-60. PubMed ID: 11591747
[TBL] [Abstract][Full Text] [Related]
20. Identification of Novel Respiratory Syncytial Virus CD4
Schmidt ME; Varga SM
Immunohorizons; 2019 Jan; 3(1):1-12. PubMed ID: 31356172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
